Invitrogen™ Human Glypican 3 ELISA Kit

Ref.: BL-RE-159558Manufacturer ref.: EH223RB 96 tests
€734.00 excl. VAT

Human Glypican 3 quantitates human Glypican 3 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Glypican 3.

Accession number
Défectueux dans le syndrome d’avance de croissance de Simpson-Golabi-Behmel ; DGSX ; glypican 3 ; glypican protéoglycane 3 ; glypican-3 ; sous-unité alpha Glypican-3 ; sous-unité bêta Glypican-3 ; GPC3 ; GTR22 ; GTR2-2 ; Protéoglycane de sulfate d’héparane ; protéine d’origine OCI-5 ; MXR7 ; OCI5 ; OCI-5 ; GPC3 protéoglycane ; SDYS ; glypican-3 sécrété ; SGB ; SGBS ; SGBS1
Dose range
0.8 to 600 ng/mL
Sensitivity of the dosage
0.8 ng/mL
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human Glypican 3 quantitates human Glypican 3 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Glypican 3.

Human Glypican 3 quantitates human Glypican 3 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Glypican 3.

GPC3 is a cellular surface proteoglycan containing d-heparane sulphate. This protein can be involved in suppressing/modulating growth in mainly mesodermal tissues and organs and can play a role in modulation of IGF2 interactions with its receptor and thus modulate its function. Glypican-bound integral membrane proteoglycans contain a cytoplasmic membrane-based nucleus protein via glycosyl phosphatidylinositol (GPI) binding. These proteins can play a role in controlling cell division, growth regulation and tumour predisposition. Deletion mutations in GPC3 are the cause of Simpson-Golabi-Behmel syndrome (SGBS), also known as Simpson's Dysmorphic Syndrome (SDYS). The SGBS is a pathology characterized by an advance in pre- and postnatal growth (gigantism) with visceral and skeletal abnormalities.

Sensitivity

Sensitivity of dosage: 0.8 ng/mL.

Measurement range

Dose range: 0.8 to 600 ng/mL.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: Glypican 3.

Samples

Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; plasma, 50 µl; serum, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17124513
Specifications
Accession numberDefective in Simpson-Golabi-Behmel growth advance syndrome; DGSX; glypican 3; glypican proteoglycan 3; glypican-3; alpha subunit Glypican-3; beta subunit Glypican-3; GPC3; GTR22; GTR2-2; Proteoglycan sulfate diheparane; protein of origin OCI-5; MXR7; OCI5;
Dose range0.8 to 600 ng/mL
Sensitivity of the dosage0.8 ng/mL
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)P51654
Gene symbol(s)GPC3
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kitsPre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity96 tests
Regulatory statusUse exclusively for research
TargetGlypican 3
Test time1 h 20 min
Physical characteristics
Volume of sampleSupernatant, 50 µl; plasma, 50 µl; serum, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH223RB
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.